DePuy Orthopaedics

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, DePuy Orthopaedics sits in the top decile of US sponsors by registered trial count (#448 of 15,742 sponsors by registered trial count).

38 total trials 2 currently recruiting 24 completed later-stage tilt top decile by trial count

DePuy Orthopaedics: 38 sponsored US clinical trials, 2 recruiting.

DePuy Orthopaedics sponsors 38 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 24 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis, with 6 trials.

Top-decile sponsor footprint

DePuy Orthopaedics ranks in the top decile of sponsors by registered trial count (#448 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 21/100

24 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

38 total, page 1 of 1

RECRUITING NA

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

NCT06631638

RECRUITING NA

INHANCE Stemless Reverse Shoulder IDE

NCT06323980

ACTIVE NOT RECRUITING NA

ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population

NCT03153449

ACTIVE NOT RECRUITING NA

ATTUNE Revision System in the Revision Total Knee Arthroplasty Population

NCT03153475

ACTIVE NOT RECRUITING NA

14022 ATTUNE Cementless RP Clinical Performance Evaluation

NCT02839850

TERMINATED NA

ATTUNE Cementless FB Tibial Base Clinical Study

NCT04630262

COMPLETED NA

Comparison of Alignment Achieved Using the VELYS Robotic-Assisted Solution Versus Manual Instrumentation in Total Knee Arthroplasty

NCT04730271

TERMINATED NA

Anterior Advantage With KINCISE

NCT04191733

TERMINATED NA

Health Partner Evaluation at Providence

NCT03443284

COMPLETED

Cup Position in THA With Standard Instruments

NCT03189303

TERMINATED NA

Health Partner Evaluation at Princeton

NCT03386786

COMPLETED NA

Actis Total Hip System 2 Year Follow-up

NCT02783274

COMPLETED NA

ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty

NCT02574312

COMPLETED NA

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

NCT02096211

COMPLETED

Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement

NCT02096198

COMPLETED

ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study

NCT01884532

COMPLETED

Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study

NCT01828801

COMPLETED

Prospective, Multiconfiguration Study to Assess Functional Performance of Primary Total Knee Arthroplasty System

NCT01746524

TERMINATED

28mm Ceramic-on-Ceramic Total Hip Replacement Study

NCT01657435

TERMINATED NA

CoMplete™ Acetabular Hip System

NCT01543230

COMPLETED

10003 PRO Current Products

NCT01497730

COMPLETED NA

Comparison of Surgical Time and Efficiency of Total Knee Arthroplasty

NCT01301950

COMPLETED NA

Alignment Comparison Between TruMatch™ Personalized Solutions and Conventional Total Knee Replacement Instrumentation

NCT01108237

COMPLETED NA

Global® AP™ Total Shoulder Arthroplasty

NCT00719771

COMPLETED NA

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

NCT00561600

COMPLETED

DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial

NCT00546429

COMPLETED NA

Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System

NCT00487565

COMPLETED NA

Does Implant Design Improve Postoperative Flexion?

NCT00380861

TERMINATED Phase 4

Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System

NCT00546598

COMPLETED NA

Metal on Metal Versus Ceramic on Metal Hip Replacement

NCT00208494

COMPLETED NA

Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study

NCT00289133

COMPLETED NA

36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement

NCT00953719

COMPLETED NA

28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study

NCT00208507

TERMINATED NA

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

NCT00306917

COMPLETED NA

Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA

NCT00289107

COMPLETED NA

Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA

NCT00289094

TERMINATED NA

Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses

NCT00289081

COMPLETED NA

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

NCT00306930

Where DePuy Orthopaedics enrollment is open (later-stage tilt)

2 recruiting of 38 indexed (5% open); 24 completed (63%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Osteoarthritis (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

DePuy Orthopaedics: open-pipeline peers nationwide

Peers matched on 38 registered trials and 5% open enrollment, not the therapeutic-area sidebar.

DePuy Orthopaedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 152025303540 0%5%10%15% Total trials Recruiting share DePuy OrthopaedicsAcerta PharmaAstex PharmaceuticalsCorewell Health WestEthiconAlmirall, S.A.Cordis USDefense and Veterans Center for Integrative Pain ManagementImpax Laboratories
DePuy Orthopaedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

DePuy Orthopaedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 38 trials (± recruiting share)

Sponsors near 5% open enrollment (± trial volume)

What to do with this DePuy Orthopaedics page

38 registered trials is a research-attention snapshot, not an endorsement of DePuy Orthopaedics or any single study.

  • 2 of DePuy Orthopaedics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Osteoarthritis is the condition DePuy Orthopaedics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

DePuy Orthopaedics pipeline card: 38 registered trials from official public datasets.Report a data error.